BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21959586)

  • 1. Simulated brain biopsy for diagnosing neurodegeneration using autopsy-confirmed cases.
    Venneti S; Robinson JL; Roy S; White MT; Baccon J; Xie SX; Trojanowski JQ
    Acta Neuropathol; 2011 Dec; 122(6):737-45. PubMed ID: 21959586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simulated surgical-type cerebral biopsies from post-mortem brains allows accurate neuropathological diagnoses in the majority of neurodegenerative disease groups.
    King A; Maekawa S; Bodi I; Troakes C; Curran O; Ashkan K; Al-Sarraj S
    Acta Neuropathol Commun; 2013 Aug; 1():53. PubMed ID: 24252649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging correlates of pathology in corticobasal syndrome.
    Whitwell JL; Jack CR; Boeve BF; Parisi JE; Ahlskog JE; Drubach DA; Senjem ML; Knopman DS; Petersen RC; Dickson DW; Josephs KA
    Neurology; 2010 Nov; 75(21):1879-87. PubMed ID: 21098403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological correlations in corticobasal degeneration.
    Lee SE; Rabinovici GD; Mayo MC; Wilson SM; Seeley WW; DeArmond SJ; Huang EJ; Trojanowski JQ; Growdon ME; Jang JY; Sidhu M; See TM; Karydas AM; Gorno-Tempini ML; Boxer AL; Weiner MW; Geschwind MD; Rankin KP; Miller BL
    Ann Neurol; 2011 Aug; 70(2):327-40. PubMed ID: 21823158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
    Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
    JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome.
    Matsumoto A; Suzuki H; Fukatsu R; Shimizu H; Suzuki Y; Hisanaga K
    Neuropathology; 2016 Feb; 36(1):77-87. PubMed ID: 26227957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological correlations in behavioural variant frontotemporal dementia.
    Perry DC; Brown JA; Possin KL; Datta S; Trujillo A; Radke A; Karydas A; Kornak J; Sias AC; Rabinovici GD; Gorno-Tempini ML; Boxer AL; De May M; Rankin KP; Sturm VE; Lee SE; Matthews BR; Kao AW; Vossel KA; Tartaglia MC; Miller ZA; Seo SW; Sidhu M; Gaus SE; Nana AL; Vargas JNS; Hwang JL; Ossenkoppele R; Brown AB; Huang EJ; Coppola G; Rosen HJ; Geschwind D; Trojanowski JQ; Grinberg LT; Kramer JH; Miller BL; Seeley WW
    Brain; 2017 Dec; 140(12):3329-3345. PubMed ID: 29053860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies.
    Thal DR; von Arnim CA; Griffin WS; Mrak RE; Walker L; Attems J; Arzberger T
    J Neural Transm (Vienna); 2015 Jul; 122(7):1007-18. PubMed ID: 25556950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of cerebral cortical lesions in corticobasal degeneration: a clinicopathological study of five autopsy cases in Japan.
    Tsuchiya K; Ikeda K; Uchihara T; Oda T; Shimada H
    Acta Neuropathol; 1997 Nov; 94(5):416-24. PubMed ID: 9386773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The application of Gallyas-Braak stainings in pathologic diagnosis of neurodegenerative diseases].
    Wang L; Zhu M; Li X; Gui Q
    Zhonghua Nei Ke Za Zhi; 2002 Feb; 41(2):120-3. PubMed ID: 11940310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosis in neurodegenerative disease: differential patterns of hallucination and delusion symptoms.
    Naasan G; Shdo SM; Rodriguez EM; Spina S; Grinberg L; Lopez L; Karydas A; Seeley WW; Miller BL; Rankin KP
    Brain; 2021 Apr; 144(3):999-1012. PubMed ID: 33501939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rates of cerebral atrophy differ in different degenerative pathologies.
    Whitwell JL; Jack CR; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Ferman TJ; Dickson DW; Josephs KA
    Brain; 2007 Apr; 130(Pt 4):1148-58. PubMed ID: 17347250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First symptom guides diagnosis and prognosis in neurodegenerative diseases-a retrospective study of autopsy proven cases.
    Vöglein J; Kostova I; Arzberger T; Roeber S; Schmitz P; Simons M; Ruf V; Windl O; Herms J; Dieterich M; Danek A; Höglinger GU; Giese A; Levin J
    Eur J Neurol; 2021 Jun; 28(6):1801-1811. PubMed ID: 33662165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathological fingerprints of survival, atrophy and language in primary progressive aphasia.
    Mesulam MM; Coventry CA; Bigio EH; Sridhar J; Gill N; Fought AJ; Zhang H; Thompson CK; Geula C; Gefen T; Flanagan M; Mao Q; Weintraub S; Rogalski EJ
    Brain; 2022 Jun; 145(6):2133-2148. PubMed ID: 35441216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis].
    Morimatsu M; Negoro K; Mori H
    Rinsho Shinkeigaku; 2004 Nov; 44(11):982-5. PubMed ID: 15651349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy.
    Boeve BF; Silber MH; Ferman TJ; Lucas JA; Parisi JE
    Mov Disord; 2001 Jul; 16(4):622-30. PubMed ID: 11481685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seizure prevalence in neurodegenerative diseases-a study of autopsy proven cases.
    Vöglein J; Kostova I; Arzberger T; Noachtar S; Dieterich M; Herms J; Schmitz P; Ruf V; Windl O; Roeber S; Simons M; Höglinger GU; Danek A; Giese A; Levin J
    Eur J Neurol; 2022 Jan; 29(1):12-18. PubMed ID: 34472165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
    Kurata T; Kametaka S; Ohta Y; Morimoto N; Deguchi S; Deguchi K; Ikeda Y; Takao Y; Ohta T; Manabe Y; Sato S; Abe K
    Intern Med; 2011; 50(22):2775-81. PubMed ID: 22082889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration.
    Forrest SL; Crockford DR; Sizemova A; McCann H; Shepherd CE; McGeachie AB; Affleck AJ; Carew-Jones F; Bartley L; Kwok JB; Kim WS; Jary E; Tan RH; McGinley CV; Piguet O; Hodges JR; Kril JJ; Halliday GM
    Neurology; 2019 May; 92(21):e2472-e2482. PubMed ID: 31019099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer's disease.
    Desmarais P; Gao AF; Lanctôt K; Rogaeva E; Ramirez J; Herrmann N; Stuss DT; Black SE; Keith J; Masellis M
    Alzheimers Res Ther; 2021 Jul; 13(1):129. PubMed ID: 34256835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.